Abstract
Summary
A consensus platform is provided by the experts of the Gulf Cooperation Council (GCC) countries’ respective osteoporosis societies, on which specific guidelines can be developed further for regional use on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis.
Introduction
Guidance is provided in a Gulf Cooperation Council (GCC) country setting on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis, which is an adaptation of the European guidance by Kanis et al., jointly published by the International Osteoporosis Foundation and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). The respective osteoporosis societies of the Gulf Cooperation Council (GCC) countries assembled for a unifying consensus on the diagnosis and management of osteoporosis in postmenopausal women for the region.
Methods
The Chair for Biomarkers of Chronic Diseases (CBCD) in King Saud University (KSU), Riyadh, Kingdom of Saudi Arabia (KSA), in cooperation with the Saudi Osteoporosis Society (SOS), hosted regional experts and respective leaders from different GCC osteoporosis societies, together with an adviser from the ESCEO. An assembly of experts representing the different osteoporosis societies from Saudi Arabia, the UAE, Bahrain, Oman, and Kuwait gathered on February 15–16, 2019 in Riyadh, KSA for the formulation of a general osteoporosis consensus for the region.
Results
The following areas were covered: diagnosis of osteoporosis and assessment of fracture risk; general and pharmacological management of osteoporosis; and hip fractures, vitamin D, recommendation on which FRAX tool to follow, and the importance of country-specific FRAX® and fracture liaison services for secondary fracture prevention.
Conclusions
A platform is provided on which specific guidelines can be developed for regional use in GCC.
Similar content being viewed by others
References
Glaser DL, Kaplan FS (1997) Osteoporosis. Definition and clinical presentation. Spine (Phila Pa 1976) 22(24 Suppl):12S–16S
World Health Organization. Recommendations for preventing osteoporosis. https://www.who.int/nutrition/topics/5_population_nutrient/en/index25.html. Accessed 16 July 2019
Cooper C, Campion G, Melton LJ 3rd. (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2(6):285–289
Oden A, McCloskey EV, Kanis JA, Harvey NC, Johansson H (2015) Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int 26(9):2243–2248
Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF) (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3–44
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 104(5):1595–1622
Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD, Narula HS, Pessah-Pollack R, Tangpricha V, Wimalawansa SJ, Watts NB (2016) American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis–2016. Endocr Pract 22(9):1111–1118
Jassim NA, Adib G, Younis AA, Gorial FI, Maghraoui A, Suhaili AR, Murtaji A, Otom A, Masri B, Saba E, Badran F, Maalouf G, Saleh J, El Muntaser K, Zakraoui L, Al Izzi M, Ali NA, Sulaimani R, Majeed SA, Al ES (2017) Pan Arab Osteoporosis Society guidelines for osteoporosis management. Mediterr J Rheumatol 28(1):37–42
Maalouf G, Gannage-Yared MH, Ezzedine J, Larijani B, Badawi S, Rached A, Zakroui L, Masri B, Azar E, Saba E, Nammari R, Adib G, Abou Samra H, Alrawi Z, Zalman S, El Muntasser K, Tarseen R, El Kharousi W, Al-Lamki M, Alothman AN, Almarzook N, El Dessouki M, Sulaimani R, Saleh J, Suhaili AR, Khan A, Delmas P, Seeman E (2007) Middle East and North Africa consensus on osteoporosis. J Musculoskeletal Neuronal Interact 7(2):131–143
Al-Saleh Y, Sulimani R, Sabico S, Raef H, Fouda M, Alshahrani F, Al Shaker M, Al Wahabi B, Sadat-Ali M, Al Rayes H, Al Aidarous S, Saleh S, Al Ayoubi F, Al-Daghri NM (2015) 2015 guidelines for osteoporosis in Saudi Arabia: recommendations from the Saudi Osteoporosis Society. Ann Saudi Med 35(1):1–12
Kuwait Osteoporosis Guidelines (2018) http://www.kops-kw.org/uploads/frax_guidelines_2018.pdf. Accessed 16 July 2019
Beshyah SA, Al-Saleh Y, EL-hajj Fuleihan G (2019) Management of osteoporosis in the Middle East and North Africa: a survey of physicians’ perceptions and practices. Arch Osteoporos 14(1):60
Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, Weber DR, Zemel BS, Shepherd JA (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA-cross calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine and pediatrics. J Clin Densitom. in-press. https://doi.org/10.1016/j.jocd.2019.07.001
Alkhamis A, Hassan A, Cosgrove P (2014) Financing healthcare in Gulf Cooperation Council countries: a focus on Saudi Arabia. Int J Health Plan Manage 29(1):e64–e82
Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos int 7(5):407–413
El-Desouki MI (1999) Osteoporosis in postmenopausal Saudi women using dual X-ray bone densitometry. Saudi Med J 20(4):283–286
El-Desouki MI (2003) Osteoporosis in postmenopausal Saudi women using dual x-ray bone densitometry. Saudi Med J 24(9):953–956
Sadat Ali M, AlElq A (2006) Osteoporosis among male Saudi Arabs: a pilot study. Ann Saudi Med 26(6):450–454
El-Desouki MI, Sulimani RA (2007) High prevalence of osteoporosis in Saudi men. Saudi Med J 28(5):774–777
Ardawi MS, Maimany AA, Bahksh TM, Nasrat HA, Milaat WA, Al-Raddadi RM (2005) Bone mineral density of the spine and femur in healthy Saudis. Osteoporos Int 16(1):43–55
Sadat Ali M, Al-Habdan IM, Al-Turki HA, Azam MQ (2012) An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population. Ann Saudi Med 32(6):637–641
Al Saleh J, Sayed ME, Monsef N, Darwish E (2016) The prevalence and the determinants of musculoskeletal diseases in Emiratis attending primary health care clinics in Dubai. Oman Med J 31(2):117–123
Alsawy S (2009) Edentulism as a predictor of osteoporosis among postmenopausal Bahraini women. J Clin Densitom 12(3):389
Mahussain S, Badr H, Al-Zaabi K, Mohammad M, Alnafisi N (2006) Bone mineral density in healthy Kuwaiti women. Arch Osteoporos 1(1-2):51–57
Al-Shoumer KA, Nair V (2012) Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait. Arch Osteoporos 7:147–153
Gupta R, Al-saeed O, Azizieh F, Albusairi A, Gupta P, Mohammed A (2012) Evaluation of bone mineral density in postmenopausal women in Kuwait. J Clin Densitom 15(2):211–216
Shukla JJ, Khandekar RB (2008) Magnitude and determinants of osteoporosis in adult population of South Sharqiya region of Oman. Saudi Med J 29(7):984–988
Bener A, Hammoudeh M, Zirie M (2007) Prevalence and predictors of osteoporosis and the impact of life style factors on bone mineral density. APLAR Journal of Rheumatology 10:227–233
The Middle East and Africa Regional Audit: Epidemiology, costs and burden of osteoporosis in 2011 (Executive Summary). https://www.iofbonehealth.org/sites/default/files/PDFs/Audit%20Middle%20East_Africa/ME_audit-executive_summary.pdf. Accessed 17 July 2019
Rouzi AA, Al-Sibiani SA, Al-Senani NS, Raddadi RM, Ardawi MS (2012) Independent predictors of all osteoporosis-related fractures among healthy Saudi postmenopausal women: the CEOR study. Bone 50(3):713–722
Sadat Ali M, Alfaraidy M, AlHawas A, Al-Othman AA, Al-Dakheel DA, Tayar BK (2017) Morbidity and mortality after fragility hip fracture in a Saudi Arabian population: report from a single center. J Int Med Res 45(3):1175–1180
Azizieh FY (2017) Fractures in Kuwait: incidence and distribution. Risk Manag Healthc Policy 10:117–125
Johansson H, Azizieh F, Al Ali N, Alessa T, Harvey NC, McCloskey E, Kanis JA (2017) FRAX- vs. T-score intervention thresholds for osteoporosis. Osteoporos Int 28(11):3099–3105
Amin TT, Al Owaifeer A, Al-Hashim H, Alwosaifer A, Alabdulqader M, Al Hulaibi F, Al Hamam A (2013) Osteoporosis among older Saudis: risk fractures and unmet needs. Arch Osteoporos 8:118
Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV, Advisory Board of the National Osteoporosis Guideline Group (2016) A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11(1):25
Chakhtoura M, Leslie WD, McClung M, Cheung AM, Fuleihan GE (2017) The FRAX-based Lebanese osteoporosis guidelines: rationale for a hybrid model. Osteoporos Int 28(1):12737
Kanis JA, Harvey NC, McCloskey E, Bruyere O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Jawad K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster JY (2020) Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int 31(1):1–12
Singh P, Kumar M, Al KS (2019) Vitamin D deficiency in the Gulf Cooperation Council: exploring the triad of genetic predisposition, the gut microbiome and the immune system. Front Immunol 10:1042
Al-Daghri NM, Al-Saleh Y, Aljohani N, Sulimani R, Al-Othman AM, Alfawaz H, Fouda M, Al-Amri F, Shahrani A, Alharbi M, ALshahrani F, Tamimi W, Sabico S, Rizzoli R, Reginster JY (2017) Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Muskuloskeletal Diseases (ESCEO). Arch Osteoporos 12(1):1
Haq A, Wimalawansa SJ, Pludowski P, Anouti FA (2018) Clinical practice guidelines for vitamin D in the United Arab Emirates. J Steroid Biochem Mol Biol 175:4–11
AlQuaiz AM, Mujammami M, Kazi Am Hasanato RM, Alodhayani A, Shaik SA, Al-Daghri NM (2019) Vitamin D cutoff point in relation to parathyroid hormone: a population based study in Riyadh city, Saudi Arabia. Arch Osteoporos 14(1):22
Sulimani RA, Mohammed AG, Alfadda AA, Alshehri SN, Al-Othman AM, Al-Daghri NM, Hanley DA, Khan AA (2016) Vitamin D deficiency and biochemical variations among urban Saudi adolescent girls according to season. Saudi Med J 37(9):1002–1008
Alshahrani FM, Almalki MH, Aljohani N, Alzahrani A, Alsaleh Y, Holick MF (2013) Vitamin D: light side and best time of sunshine in Riyadh, Saudi Arabia. Dermato-Endocrinology 5(1):177–180
Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23–57
Acknowledgments
The authors are grateful to the guidance and permission provided by IOF and ESCEO in adapting the European guidelines for GCC use. The authors are grateful to the Chair for Biomarkers of Chronic Diseases, Deanship of Scientific Research Chairs in King Saud University, Riyadh, Saudi Arabia, for their support.
Author information
Authors and Affiliations
Contributions
The views expressed in this article represent the outcomes of a working group jointly organized by the Chair for Biomarkers of Chronic Diseases (NMA) and Saudi Osteoporosis Society (YS, RS) in King Saud University, Riyadh, Saudi Arabia, on February 15–16, 2019. The working group are representatives of their respective osteoporosis societies within the GCC, together with the president of ESCEO (JYR) who served as adviser, and were invited for their expertise in osteoporosis. Members of the working group (YS, NMA, TA, AA, MA, JM, SAQ, JYR, AS, and RS) were assigned topics of importance relevant to the region in advance of the meeting for discussion. Following the meeting, a first draft was made (SS) and was circulated to all including those who were not able to attend (FA, SAE) for their review and input. Following 3 rounds of review from all members, the final draft was formatted and submitted by YS. All authors met the ICMJE criteria for authorship and gave final approval of the version to be published.
Corresponding author
Ethics declarations
Conflicts of interest
YS received speaker honoraria from Eli Lilly and Amgen. TA received speaker honoraria from Amgen and Novartis. JYR received consulting fees and/or paid advisory boards for IBSA-Genevrier, MYLAN, Radius Health, and Pierre Fabre; lecture fees when speaking at the invitation of IBSA-Genevrier, MYLAN, CNIEL, and Diary Research Council (DRC); and grant support from IBSA-Genevrier, MYLAN, CNIEL, and Radius Health. NMA, SS, TA, AA, MA, JM, SAQ, AS, and RS have no conflicts to declare.
Additional information
Endorsements
This consensus report is endorsed by the following societies:
Saudi Osteoporosis Society
Kuwait Osteoporosis Society
American Association of Clinical Endocrinologists, Gulf Chapter
Emirates Osteoporosis Society
Emirates Diabetes Society
Oman Medical Association
Bahrain Osteoporosis Society
Qatar Osteoporosis Society
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Al-Saleh, Y., Al-Daghri, N.M., Sabico, S. et al. Diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries: consensus statement of the GCC countries’ osteoporosis societies under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Arch Osteoporos 15, 109 (2020). https://doi.org/10.1007/s11657-020-00778-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11657-020-00778-5